Neck circumference as an independent indicator to non-alcoholic fatty liver disease in non-obese men
Tóm tắt
To investigate the relationship of the neck circumference (NC) with non-alcoholic fatty liver disease (NAFLD) in non-obese Chinese population. Our data were obtained from a cross-sectional survey on the prevalence of metabolic diseases and risk factors in East China in 2014. Subjects with a BMI ≥ 18.5 kg/m2 and < 25 kg/m2 were considered normal weight. A total of 2668 participants aged 18–89 were identified for analysis. Anthropometric indices, biochemical parameters, clinical characteristics and abdominal ultrasound were measured. Independent predictors of NAFLD were identified by multiple logistic regressions. The overall prevalence of NAFLD was 10.94 % in this study population and men had a higher prevalence than women (19.89 % vs 7.48 %, P < 0.01). The mean NC was greater in NAFLD subjects compared with other groups in both genders (P < 0.01). NC was correlated to BMI, waist circumference, hip circumference, systolic blood pressure, diastolic blood pressure, insulin, HOMA-IR, triglycerides and ALT, regardless of sex. In the highest quartile of NC levels in men but not in women, the risks were substantially higher for NAFLD [odds ratio 2.18, (95 % confidence interval 1.16–4.13)] (P < 0.001 for trend) after adjusting for potential confounding factors. NC was an independent indicator for NAFLD in normal weighted men.
Tài liệu tham khảo
Karpe F, Pinnick KE. Biology of upper-body and lower-body adipose tissue--link to whole-body phenotypes. Nat Rev Endocrinol. 2015;11(2):90–100.
Liang J, Wang Y, Dou L, Li H, Liu X, Qiu Q, et al. Neck circumference and prehypertension: the cardiometabolic risk in Chinese study. J Hypertens. 2015;33(2):275–8.
Onat AH G, Yuksel H, Can G, Ayhan E, Kaya Z, Dursunoglu D. Neck circumference as a measure of central obesity: Associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference. Clin Nutr. 2009;28(1):46–51.
LA Ben-Noun LL. Relationship between changes in neck circumference and changes in blood pressure. Am J Hypertens. 2004;17(5 Pt 1):409–14.
Androutsos OGE, Moschonis G, Roma-Giannikou E, Chrousos GP, Manios Y, Kanaka-Gantenbein C. Neck circumference: a useful screening tool of cardiovascular risk in children. Pediatr Obes. 2012;7(3):187–95.
Yoo HJ, Park MS, Lee CH, Yang SJ, Kim TN, Lim KI, et al. Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians. Liver Int. 2010;30(8):1189–96.
Nishioji K, Sumida Y, Kamaguchi M, Mochizuki N, Kobayashi M, Nishimura T, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012. J Gastroenterol. 2015;50(1):95–108.
Huang BX, Zhu MF, Wu T, Zhou JY, Liu Y, Chen XL, et al. Neck circumference, along with other anthropometric indices, has an independent and additional contribution in predicting fatty liver disease. Plos One. 2015;10(2):e0118071.
Akelma AZ, Abaci A, Ozdemir O, Celik A, Avci Z, Razi CH, et al. The association of serum lipocalin-2 levels with metabolic and clinical parameters in obese children: a pilot study. J Pediatr Endocrinol Metab. 2012;25(5–6):525–8.
Hao YPMX, Luo YQ, Ni J, Dou JX, Hu YQ, Zhu JA, et al. Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes. Acta Pharmacol Sin. 2014;35(9):1150–6.
Preis SR MJ, Hoffmann U, D'Agostino Sr RB, Levy D, Robins SJ, Meigs JB, et al. Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab. 2010;95(8):3701–10.
Wang N, Kuang L, Han B, Li Q, Chen Y, Zhu C, et al. Follicle-stimulating hormone associates with prediabetes and diabetes in postmenopausal women. Acta Diabetol. 2015. Epub ahead of print.
Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310(9):948–59.
Guicheng Peng ML, Kun Z, Jie C, Yifang W, Yu Y, Jingfeng W, et al. Hemoglobin A1c can identify more cardiovascular and metabolic risk profile in OGTT-negative Chinese population. Int J Med Sci. 2013;10:1028–34.
Huating Li KD, Qichen F, Xuhong H, Mi Z, Yuqian B, Kunsan X, et al. High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China. J Hepatol. 2013;58:557–63.
Chitturi SFG, Hashimoto E, Saibara T, Lau GK, Sollano JD. Nonalcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol. 2007;22:778–87.
Sung KCRM, Wilson AM. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis. 2009;203:581–6.
Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40(8):745–52.
Yuan H, Shyy JY, Martins-Green M. Second-hand smoke stimulates lipid accumulation in the liver by modulating AMPK and SREBP-1. J Hepatol. 2009;51(3):535–47.
Azzalini L, Ferrer E, Ramalho LN, Moreno M, Dominguez M, Colmenero J, et al. Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats. Hepatology. 2010;51(5):1567–76.
Agarwal R. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy. BMC Nephrol. 2005;6:13.
Malfertheiner P, Schutte K. Smoking--a trigger for chronic inflammation and cancer development in the pancreas. Am J Gastroenterol. 2006;101(1):160–2.
Zein CO, Unalp A, Colvin R, Liu YC, McCullough AJ. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol. 2011;54(4):753–9.
Albano EME, Occhino G. Role of oxidative stress in the progression of nonalcoholic steatohepatitis. Aliment Pharmacol Ther. 2005;22:71–3.
Juanwen Zhang YZ, Chengfu X, Yani H, Huanle L, Jianping W, Yu C. Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study. Sci Rep. 2014;25(4):5842.
Stabe C, Vasques AC, Lima MM, Tambascia MA, Pareja JC, Yamanaka A, et al. Neck circumference as a simple tool for identifying the metabolic syndrome and insulin resistance: results from the Brazilian Metabolic Syndrome Study. Clin Endocrinol (Oxf). 2013;78:874–81.
Chang YRS, Sung E, Woo HY, Cho SI, Yoo SH, Ahn HY, et al. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut. 2009;58(10):1419–25.
Sattar NFE, Preiss D. Non-alcoholic fatty liver disease. Br Med J. 2014;29(349):g4596.